Page last updated: 2024-08-23

azides and Carcinoma, Non-Small Cell Lung

azides has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, HY; Chao, SW; Chen, MY; Chiu, HW; Hu, FH; Huang, WJ; Juan, HF; Lin, P; Tang, YA; Wang, TW; Wang, YC; Wang, YJ; Yeh, YL	1
Ambudkar, SV; Bahr, JC; Bates, SE; Di Pietro, A; Macalou, S; Obrzut, T; Polgar, O; Robey, RW; Shukla, S	1

Other Studies

2 other study(ies) available for azides and Carcinoma, Non-Small Cell Lung

Article	Year
A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies. Cancer letters, 2014, Apr-28, Volume: 346, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azides; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Mice, Inbred BALB C; Reverse Transcriptase Polymerase Chain Reaction; Xenograft Model Antitumor Assays	2014
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:3 Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Azides; Biological Transport; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescence; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Immunoblotting; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Proteins; Prazosin	2009

Article

Year

A histone deacetylase inhibitor YCW1 with antitumor and antimetastasis properties enhances cisplatin activity against non-small cell lung cancer in preclinical studies.

Cancer letters, 2014, Apr-28, Volume: 346, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azides; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Mice, Inbred BALB C; Reverse Transcriptase Polymerase Chain Reaction; Xenograft Model Antitumor Assays

2014

Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.

Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:3

Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Azides; Biological Transport; Carbazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescence; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Immunoblotting; Iodine Radioisotopes; Lung Neoplasms; Neoplasm Proteins; Prazosin

2009